Literature DB >> 2191954

Molecular cloning of a cDNA for rat hepatic glutaminase. Sequence similarity to kidney-type glutaminase.

E M Smith1, M Watford.   

Abstract

Mammalian liver possesses a unique isozyme of phosphate-activated glutaminase which plays an important role in the regulation of glutamine catabolism. Antibodies to hepatic glutaminase were used to screen a lambda gt11 rat liver cDNA library. One cDNA to hepatic glutaminase was identified. Changes in the relative abundance of hepatic glutaminase mRNA were determined by hybridization to this cDNA. The mRNA is found only in liver; it is not present prior to birth but its abundance increases dramatically at birth. The abundance of the mRNA is increased approximately 4-fold in diabetes. The sequence of the cDNA was compared to that recently published for kidney (brain)-type glutaminase (Banner, C., Hwang, J.-J., Shapiro, R.A., Wenthold, R.J., Nakatani, Y., Lampel, K.A., Thomas, J.W., Huie, D., and Curthoys, N.P. (1988) Mol. Brain Res. 3, 247-254). When the predicted amino acid sequences were compared a region of 123 amino acids with greater than 80% identity was found. The presence of scattered amino acid substitutions within stretches of identical amino acids suggests that the glutaminase isozymes are encoded by separate genes. This is the first demonstration of any similarity between the two glutaminases at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191954

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase.

Authors:  P M Gómez-Fabre; J C Aledo; A Del Castillo-Olivares; F J Alonso; I Núñez De Castro; J A Campos; J Márquez
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  Identification of two glutaminases in Rhizobium etli.

Authors:  S Durán; L Sánchez-Linares; A Huerta-Saquero; G Du Pont; A Huerta-Zepeda; J Calderón
Journal:  Biochem Genet       Date:  1996-12       Impact factor: 1.890

3.  Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter.

Authors:  M E de Vera; R A Shapiro; A K Nussler; J S Mudgett; R L Simmons; S M Morris; T R Billiar; D A Geller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

4.  Distribution of albumin, alpha 1-inhibitor 3 and their respective mRNAs in periportal and perivenous rat hepatocytes isolated by the digitonin-collagenase technique.

Authors:  L Racine; J Y Scoazec; A Moreau; P Chassagne; D Bernuau; G Feldmann
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

Review 5.  Glutamate and Brain Glutaminases in Drug Addiction.

Authors:  Javier Márquez; José A Campos-Sandoval; Ana Peñalver; José M Matés; Juan A Segura; Eduardo Blanco; Francisco J Alonso; Fernando Rodríguez de Fonseca
Journal:  Neurochem Res       Date:  2016-12-23       Impact factor: 3.996

6.  Rat hepatic glutaminase: identification of the full coding sequence and characterization of a functional promoter.

Authors:  M I Chung-Bok; N Vincent; U Jhala; M Watford
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

7.  Glutamine catabolism by heart muscle. Properties of phosphate-activated glutaminase.

Authors:  D Nelson; W L Rumsey; M Erecińska
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

8.  Genomic organization and transcriptional analysis of the human l-glutaminase gene.

Authors:  Cristina Pérez-Gómez; José M Matés; Pedro M Gómez-Fabre; Antonio del Castillo-Olivares; Francisco J Alonso; Javier Márquez
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

9.  Evolutionary relationships of the carbamoylphosphate synthetase genes.

Authors:  M J van den Hoff; A Jonker; J J Beintema; W H Lamers
Journal:  J Mol Evol       Date:  1995-12       Impact factor: 2.395

10.  Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).

Authors:  Mary M Robinson; Steven J McBryant; Takashi Tsukamoto; Camilo Rojas; Dana V Ferraris; Sean K Hamilton; Jeffrey C Hansen; Norman P Curthoys
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.